CPBIO Holding Company Limited (CAIHF)

OTCMKTS · Delayed Price · Currency is USD

1.068

+0.788 (281.43%)

At close: Aug 13, 2026

Market Cap	261.59M -5.1%
Revenue (ttm)	423.98M -18.9%
Net Income	24.43M -6.9%
EPS	0.10 -6.9%
Shares Out	n/a
PE Ratio	10.71
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	240
Open	1.068
Previous Close	0.280
Day's Range	1.068 - 1.068
52-Week Range	1.068 - 1.068
Beta	3.98
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 10, 2026

About CPBIO Holding Company

CPBIO Holding Company Limited manufactures and sells animal health products and chlortetracycline in Mainland China, the Asia Pacific, the Americas, Europe, and internationally. It operates through two segments: Biotech Business and Investment Business. The Biochemical segment is engaged in the manufacture and/or sale of animal health products and chlortetracycline, which are used as feed additives to promote growth of livestock, prevent or cure animal diseases, and enhance efficiency under the Shihao and Citifac brand names. The company offers... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1987

Employees 1,000

Stock Exchange OTCMKTS

Ticker Symbol CAIHF

Financial Performance

In 2025, CPBIO Holding Company's revenue was $535.91 million, an increase of 74.14% compared to the previous year's $307.75 million. Earnings were $32.06 million, an increase of 187.03%.

Financial Statements